Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes

Clinical Nephrology

Volumn 64, Issue 3, 2005, Pages 198-204

  Wu, C C ^a   Liao, T N ^b   Lu, K C ^c   Chen, J S ^a   Chu, P ^a   Lin, S H ^a   Chuang, C H ^a   Lin, Y Feng ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Biocompatibility; Hemodialysis; Mononuclear cells

Indexed keywords

C REACTIVE PROTEIN; CD19 ANTIGEN; CD3 ANTIGEN; CELLULOSE; FAS ANTIGEN; FAS LIGAND; POLYSULFONE; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; DIALYSIS MEMBRANE; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTOPENIA; MALE; MONOCYTE; NEUTROPHIL; PATIENT SELECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; UREMIA;

EID: 24644517559     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64198     Document Type: Article

References (28)

1. Bhaskaran M, Ranjan R, Shah H, Siu J, Colvin R, Radhakrishnan N, Reddy K, Franki N, Wagner JD, Singhal PC 2002 Lymphopenia in dialysis patients: a preliminary study indicating a possible role of apoptosis. Clin Nephrol 57: 221-229
2. Carracedo J, Ramirez R, Madueno JA, Soriano S, Rodriguez-Benot A, Rodriguez M, Martin-Malo A, Aljama P 2002 Cell apoptosis and hemodialysis-induced inflammation. Kidney Int Suppl: S89-S93
3. Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Aljama P 2002 The effect of LPS, uraemia, and hemodialysis membrane exposure on CD14 expression in mononuclear cells and its relation to apoptosis. Nephrol Dial Transplant 17: 428-434
4. Carracedo J, Ramirez R, Pintado O, Gomez-Villamandos JC, Martin-Malo A, Rodriguez M, Aljama P 1995 Cell aggregation and apoptosis induced by hemodialysis membranes. J Am Soc Nephrol 6: 1586-1591
5. Cohen G, Haag-Weber M, Horl WH 1997 Immune dysfunction in uremia. Kidney Int Suppl 62: S79-S82
6. Cohen JJ, Duke RC, Fadok VA, Sellins KS 1992 Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267-293
7. Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS 1977 Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 879-888
8. Descamps-Latscha B, Herbelin A, Nguyen AT, Jungers P, Chatenoud L 1995 Dysregulation of the immune system in chronic uremic and hemodialysed patients. Presse Med 24: 405-410
9. Girndt M, Kaul H, Leitnaker CK, Sester M, Sester U, Kohler H 2001 Selective sequestration of cytokine-producing monocytes during hemodialysis treatment. Am J Kidney Dis 37: 954-963
10. Girndt M, Ulrich C, Kaul H, Sester U, Sester M, Kohler H 2003 Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int Suppl: S76-S79
11. Gu Y, Ding F, Qin H, Zhao H, Lin S 2000 Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients. Chin Med J (Engl) 113: 315-319
12. Heidenreich S, Schmidt M, Bachmann J, Harrach B 1996 Apoptosis of monocytes cultured from long-term hemodialysis patients. Kidney Int 49: 792-799
13. Horl WH 2002 Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 13 Suppl 1: S62-S71
14. Kaplow LS, Goffinet JA 1968 Profound neutropenia during the early phase of hemodialysis. JAMA 203: 1135-1137
15. Krammer PH 2000 CD95's deadly mission in the immune system. Nature 407: 789-795
16. Kreuzer KA, Rockstroh JK, Sauerbruch T, Spengler U 1996 A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-α. J Immunol Methods 195: 49-54
17. Linnenweber S, Lonnemann G 2001 Effects of dialyzer membrane on interleukin-1β (IL-1β) and IL-1β-converting enzyme in mononuclear cells. Kidney Int Suppl 78: S282-S285
18. Lonnemann G, Barndt I, Kaever V, Haubitz M, Schindler R, Shaldon S, Koch KM 1995 Impaired endotoxin-induced interleukin-1β secretion, not total production, of mononuclear cells from ESRD patients. Kidney Int 47: 1158-1167
19. Lonnemann G, Barndt I, Kaever V, Haubitz M, Schindler R, Shaldon S, Koch KM 1995 Impaired endotoxin-induced interleukin-1β secretion, not total production, of mononuclear cells from ESRD patients. Kidney Int 47: 1158-1167
20. Martin-Malo A, Carracedo J, Ramirez R, Rodriguez-Benot A, Soriano S, Rodriguez M, Aljama P 2000 Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol 11: 936-942
21. Matsumoto Y, Shinzato T, Amano I, Takai I, Kimura Y, Morita H, Miwa M, Nakane K, Yoshikai Y, Maeda K 1995 Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun 215: 98-105
22. Meager A, Bird C, Mire-Sluis A 1996 Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors. J Immunol Methods 191: 97-112
23. Moser B, Roth G, Brunner M, Lilaj T, Deicher R, Wolner E, Kovarik J, Boltz-Nitulescu G, Vychytil A, Ankersmit HJ 2003 Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, hemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 308: 581-585
24. Odaka C, Mizuochi T 2000 Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals. Clin Exp Immunol 121: 515-522
25. Pupim LB, Himmelfarb J, McMonagle E, Shyr Y, Ikizler TA 2004 Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 65: 2371-2379
26. Schindler R, Boenisch O, Fischer C, Frei U 2000 Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol 53: 452-459
27. Tolkoff-Rubin NE, Rubin RH 1990 Uremia and host defenses. N Engl J Med 322: 770-772
28. van Riemsdijk-Van Overbeeke IC, Baan CC, Knoop CJ, Loonen EH, Zietse R, Weimar W 2001 Quantitative flow cytometry shows activation of the TNF-α system but not of the IL-2 system at the single cell level in renal replacement therapy. Nephrol Dial Transplant 16: 1430-1435